LakeShore Biopharma Co., Ltd. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2023 to Q1 2024

Taxonomy & unit
us-gaap: CNY and USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
LakeShore Biopharma Co., Ltd. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2023 to Q1 2024.
  • LakeShore Biopharma Co., Ltd. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $1.03M, a 36.7% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $1.03M -$595K -36.7% Mar 31, 2024 20-F 2024-08-15
Q1 2023 $1.62M Mar 31, 2023 20-F 2023-07-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.